CVC Capital Partners has acquired a 50% stake in Germany-based DFE Pharma, a manufacturer of excipients for the pharmaceutical industry, from New Zealand-listed dairy company Fonterra for NZD 633m (€363m).
Asset is reportedly due to come to market in 2021, with the sale process most likely starting in H1
Redalpine has led a series-A funding round for Germany-headquartered pet healthcare startup Felmo.
GP intends to boost the company's growth and consolidate its market position in the Benelux and DACH regions
GP is deploying equity via WMS III and is investing with future managing director Holger Schmitz